IFITM1 Targets HIV-1 Latently Infected Cells for Antibody-Dependent Cytolysis

JCI insight- United States

doi 10.1172/jci.insight.85811

Full Text

Abstract

Available in

Date

January 12, 2017

Authors

Rui André Saraiva Raposo

Miguel de Mulder Rougvie

Dominic Paquin-Proulx

Publisher

American Society for Clinical Investigation

Related search

Global Dynamics of a Class of HIV-1 Infection Models With Latently Infected Cells

Nonlinear Analysis: Modelling and Control

Applied Mathematics

Analysis

2015

English

Regulated Zinc Finger Nucleases (ZFNs) by HIV-1 Tat to Excise HIV-1 From Host Genome in Infected and Latently Infected Cells

Molecular Therapy - Nucleic Acids

Drug Discovery

Molecular Medicine

2018

English

Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+T Cells to HIV-1-Specific CD8+T Cells

English

The Bromodomain and Extraterminal Domain Inhibitor Bromosporine Synergistically Reactivates Latent HIV-1 in Latently Infected Cells

Oncotarget

Oncology

2017

English

HIV Rebounds From Latently Infected Cells, Rather Than From Continuing Low-Level Replication

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

2008

English

Nonnucleoside Reverse Transcriptase Inhibitors Reduce HIV-1 Production From Latently Infected Resting CD4 + T Cells Following Latency Reversal

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2016

English

CD4- And Time-Dependent Susceptibility of HIV-1-infected Cells to ADCC

English

Decelerating Decay of Latently Infected Cells During Prolonged Therapy for Human Immunodeficiency Virus Type 1 Infection

English

Antibody-Dependent Enhancement of Human Immunodeficiency Virus Type 1 (HIV-1) Infection in Vitro by Serum From HIV-1-infected and Passively Immunized Chimpanzees.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1989

English

Amanote Research

IFITM1 Targets HIV-1 Latently Infected Cells for Antibody-Dependent Cytolysis

JCI insight- United States

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Global Dynamics of a Class of HIV-1 Infection Models With Latently Infected Cells

Regulated Zinc Finger Nucleases (ZFNs) by HIV-1 Tat to Excise HIV-1 From Host Genome in Infected and Latently Infected Cells

Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+T Cells to HIV-1-Specific CD8+T Cells

The Bromodomain and Extraterminal Domain Inhibitor Bromosporine Synergistically Reactivates Latent HIV-1 in Latently Infected Cells

HIV Rebounds From Latently Infected Cells, Rather Than From Continuing Low-Level Replication

Nonnucleoside Reverse Transcriptase Inhibitors Reduce HIV-1 Production From Latently Infected Resting CD4 + T Cells Following Latency Reversal

CD4- And Time-Dependent Susceptibility of HIV-1-infected Cells to ADCC

Decelerating Decay of Latently Infected Cells During Prolonged Therapy for Human Immunodeficiency Virus Type 1 Infection

Antibody-Dependent Enhancement of Human Immunodeficiency Virus Type 1 (HIV-1) Infection in Vitro by Serum From HIV-1-infected and Passively Immunized Chimpanzees.